Operates a small pharmaceutical business alongside a residual jewellery trade, with FY26 revenue of Rs. 4.25 crore and a reported EBITDA margin of 42.4 percent. The company, formerly Deep Diamond India Limited, has shifted focus toward health, agro-tourism and investments, and is classified in the Gems, Jewellery and Watches basic industry. A Pharmaceutical Business segment generated Rs. 0.25 crore of revenue and Rs. 0.0524 crore EBIT in the period ended March 2026, while a Jewellery Business segment that was active in earlier quarters showed no revenue in FY26. Other Income contributed Rs. 0.18 crore EBIT in the same period. The biggest expense line is other operating expenses at 17.1 percent of FY26 revenue, with employee costs at 4.4 percent and materials at 0 percent. Recent activity includes a Rs. 19.92 crore cash acquisition of a 6.37 percent stake (90.3 lakh shares at Rs. 22.06 per share) in Leapfrog Engineering Services, an EPCC firm serving oil and gas, pharma, food processing, metals and chemicals. The company also paid Rs. 2.85 crore as advance for about 49,100 sq. mtr. of land in Pune, Maharashtra, earmarked for a naturopathy centre, holistic rejuvenation centre, medicinal plant cultivation and agro-tourism. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Pharmaceutical Business, Jewellery Business, Other Income. Small-scale, transitioning from gems and jewellery to pharmaceutical, wellness and equity investments
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 3 | 1 | 4 |
| EBITDA (ex other income) | (0) | 0 | (2) |
| margin % | (10.4) | 36.1 | (57.3) |
| Owners' profit | 0 | 1 | 1 |
| EPS, as reported (₹) | 0.14 | 0.18 | 0.12 |
| ROE % · ROCE % | 2.0 · 4.0 | 3.8 · 5.3 | 2.2 · 3.5 |
| Debt / equity (x) | 0.08 | 0.03 | 0.01 |
| Cash from operations | (5) | 0 | (4) |
| Capex | 0 | (0) | (0) |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 0 | 0 | 3 | 1 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 3 | 4 | (6) |
| Net profit | 0 | 0 | 0 | 0 | 0 | 3 | 3 | (5) |
| EPS (₹) | 0.06 | 0.09 | (0.07) | 0.07 | 0.10 | 0.54 | 0.21 | 0.48 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| Khazanchi Jewellers Limited | 1,868 | 13.2 | 5.85 | — | 28.0 | 37.7 | — | 6.8 |
| PNGS GARGI FASHION JEWELLERY L | 635 | 13.4 | 4.47 | — | 22.1 | 27.0 | — | 30.4 |
| UDAY JEWELLERY INDS. LTD. | 584 | 22.1 | 2.82 | — | 17.2 | 23.1 | — | 8.3 |
| KD GREEN INDUSTRIES LTD | 285 | 18.1 | 3.97 | 31.8 | 7.0 | 8.6 | — | 16.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · Independent Director Mr. Rajesh Pherwani resigns citing personal reasons | management changes | medium | — | — |
| 11 Sept 2026 · Independent Director resigns from Deep Health AI India | management changes | medium | — | — |
| 8 Sept 2026 · AGM Notice and Annual Report FY 2025-26 Availability | compliance | minimal | — | — |
| 8 Sept 2026 · AGM notice and e-voting details published in newspapers | compliance | minimal | — | — |
| 7 Sept 2026 · Deep Health AI India files 32nd Annual Report and AGM notice | results | high | — | — |
| 7 Sept 2026 · 32nd AGM on Sep 30, 2026: auditor change, director appointments, MD pay revision | board shareholder meetings | low | — | — |
| 6 Sept 2026 · Newspaper notice published for 32nd AGM on September 30, 2026 | compliance | minimal | — | — |
| 3 Sept 2026 · Board meeting outcomes: AGM on Sept 30, MD pay revision, new director and auditor | board shareholder meetings | medium | — | — |
| 3 Sept 2026 · Board approves 32nd AGM, new auditor, director and MD pay revision | board shareholder meetings | medium | — | — |
| 3 Sept 2026 · Board approves AGM, new independent director and auditor change | board shareholder meetings | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| GOLKUNDA DIAMONDS & JEWELLERY |
| 230 |
| 16.8 |
| 2.87 |
| — |
| 17.1 |
| 20.7 |
| — |
| 9.0 |
| AJC Jewel Manufacturers Limite | 164 | 39.2 | — | — | — | 28.7 | — | — |
| Ashapuri Gold Ornament Limited | 152 | 7.3 | 0.91 | — | 11.1 | 15.0 | — | 11.4 |
| Patdiam Jewellery Limited | 140 | 7.5 | — | — | — | — | — | — |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 1.4 | 13.3 | 4 of 54 | 94% |
| P/B | 0.5 | 0.9 | 8 of 37 | 81% |
| ROCE | 3.4 | 3.9 | 29 of 52 | 45% |
| ROE | 2.2 | 2.5 | 23 of 40 | 44% |
| Debt / Equity | 0.0 | 0.1 | 16 of 40 | 62% |
| EBITDA margin | (2214.5) | 6.8 | 35 of 35 | 0% |
| Revenue growth | (44.4) | 13.8 | 27 of 36 | 26% |
| Profit growth | (1385.5) | 1.4 | 34 of 34 | 0% |
| Market cap | 26 | 27 | 29 of 54 | 47% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
